Learn about the personalised treatments we offer and why Vie Aesthetics is your trusted partner in health and wellness
Tirzepatide: FDA-approved dual GIP/GLP-1 agonist with up to 22.5% weight loss
REF 1593 11/2022 You are encouraged to report adverse drug events (ADEs) to American Regent: T 1.800.734.9236
(2015), BioMed Research International 2015:648108, PubMed 26236730 Statistics from research literature Discovered by Loren Pickart in human blood plasma in 1973 , as a factor extending the longevity of cultured liver cells The smallest peptide with documented pharmacological activity: 3 amino acids (Gly-His-Lys) + one Cu ion Molecular weight: 402 Da EU cosmetic INCI name: Copper Tripeptide-1 (registered in EU Commission CosIng database) Gene expression modulation: 4 000 human genes (Connectivity Map dataset, Pickart 2015) Plasma level in healthy humans declines from ~200 ng/mL at age 20 to ~80 ng/mL at age 60 (62 % decrease) Most-studied bioactivities: fibroblast proliferation , type I/III collagen synthesis , antioxidant activity (SOD upregulation) Reference sources (PubMed) Pickart L., Vasquez-Soltero JM., Margolina A
Heerspink Hiddo JL, Stefnsson Bergur V, Correa-Rotter R, et al
